GKFF
CLBT icon

George Kaiser Family Foundation’s Cellebrite CLBT Stock Holding History

George Kaiser Family Foundation’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
169,640
+64,834
+62% +$857K 0.24% 17
2026
Q1 		$1.44M Buy
+104,806
New +$1.58M 0.16% 20

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

George Kaiser Family Foundation's CLBT Position: Q2 2026 in Review

George Kaiser Family Foundation increased its Cellebrite (CLBT) stake by 62% in Q2 2026, buying an estimated $857K and bringing the position to 169,640 shares worth $2.48M. The position accounts for 0.24% of the portfolio, ranked #17.

George Kaiser Family Foundation first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • George Kaiser Family Foundation held 169,640 shares of Cellebrite worth $2.48M as of Q2 2026.
  • George Kaiser Family Foundation bought 64,834 Cellebrite shares in Q2 2026, an estimated $857K.
  • Cellebrite made up 0.24% of George Kaiser Family Foundation's portfolio in Q2 2026, its #17 holding.
  • George Kaiser Family Foundation first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on George Kaiser Family Foundation's 13F filing for Q2 2026, filed 12 Aug 2026.